News

About
Research
Clinical Trials
Partnering
- Out-licensed HCV Products
- Out-licensing Opportunities
News
Careers
Investors

News Release RSS Feed (opens in new window)

Select Year: Category:

Quick Links

Investor FAQs
Governance Documents
SEC Filings

IR Contact

Jennifer Viera

Investor Relations and Corporate Communications

Enanta Pharmaceuticals, Inc.

Phone: 617-744-3848

Email: jviera@enanta.com

Investor Alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

* Required

Email Address *

Mailing Lists *

News
Events & Presentations
Quarterly Results
Annual Reports
SEC Filings
End of Day Stock Quote



Enter the code shown above.

Email Alert Sign Up Confirmation

About
Research
News
Careers
Investors

Copyright Enanta Pharmaceuticals, Inc

Privacy Policy
Twitter Policy
Terms Of Use

Powered By Q4 Inc. 5.66.0.1 (opens in new window)